Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00949117 · OUTCOME

Change in Weight for Age Z-score From Baseline Through 24 Weeks

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer · Source last updated 2014-04-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
z score
Interval / dispersion
Standard Deviation
Time frame
Baseline and 24 weeks

What was measured

Change in weight for age Z-score from Baseline through 24 weeks while on study treatment. Weight for age Z-score calculated using the Center for Disease Control and Prevention (CDC) weight-for-age Z score data tables.

Groups in this outcome

Arm I- Cyproheptadine Hydrochloride

Patients receive oral cyproheptadine hydrochloride twice daily for up to 24 weeks in the absence of weight loss or unacceptable toxicity. cyproheptadine hydrochloride: Given orally

Cyproheptadine HCl & PediaSure or Ensure

Patients receive oral cyproheptadine hydrochloride twice daily and oral PediaSure (2 to 10 years of age) or Ensure (\> 10 years of age) twice daily for up to 24 weeks in the absence of weight loss or unacceptable toxicity. Ensure: Given orally PediaSure: Given orally cyproheptadine hydrochloride: Given orally

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I- Cyproheptadine Hydrochloride1
Cyproheptadine HCl & PediaSure or Ensure0

Reported measurements

Source class 1
Values in z score · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Arm I- Cyproheptadine Hydrochloride1.470Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        0
        value
        1.47
denoms
  1. counts
    1. group Id
      OG000
      value
      1
    2. group Id
      OG001
      value
      0
    units
    Participants
description
Change in weight for age Z-score from Baseline through 24 weeks while on study treatment. Weight for age Z-score calculated using the Center for Disease Control and Prevention (CDC) weight-for-age Z score data tables.
dispersion Type
Standard Deviation
groups
  1. description
    Patients receive oral cyproheptadine hydrochloride twice daily for up to 24 weeks in the absence of weight loss or unacceptable toxicity. cyproheptadine hydrochloride: Given orally
    id
    OG000
    title
    Arm I- Cyproheptadine Hydrochloride
  2. description
    Patients receive oral cyproheptadine hydrochloride twice daily and oral PediaSure (2 to 10 years of age) or Ensure (\> 10 years of age) twice daily for up to 24 weeks in the absence of weight loss or unacceptable toxicity. Ensure: Given orally PediaSure: Given orally cyproheptadine hydrochloride: Given orally
    id
    OG001
    title
    Cyproheptadine HCl & PediaSure or Ensure
param Type
MEAN
reporting Status
POSTED
time Frame
Baseline and 24 weeks
title
Change in Weight for Age Z-score From Baseline Through 24 Weeks
type
SECONDARY
unit Of Measure
z score

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice